Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 9-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.
SHSE:688580's 9-Day RSI is ranked better than 82.31% of 865
companies
in the Medical Devices & Instruments industry
Industry Median: 45.84
vs SHSE:688580: 39.54
Nanjing Vishee Medical Technology Co (SHSE:688580) 9-Day RSI Explanation
The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.
Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.
RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 9-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.
Nanjing Vishee Medical Technology Co 9-Day RSI Related Terms
SHSE:688580 vs ABT, SYK, MDT: 9-Day RSI Comparison
For the Medical Devices subindustry, Nanjing Vishee Medical Technology Co's 9-Day RSI, along with its competitors' market caps and 9-Day RSI data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Nanjing Vishee Medical Technology Co 9-Day RSI vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Nanjing Vishee Medical Technology Co's 9-Day RSI distribution charts can be found below:
* The bar in red indicates where Nanjing Vishee Medical Technology Co's 9-Day RSI falls into.
Nanjing Vishee Medical Technology Co (SHSE:688580) 9-Day RSI Calculation
The formula for calculating RSI is:
RSI
=
100
–
[ 100
/
( 1 + Average Gain
/
Average Loss )]
* Note that the formula uses a positive value for the average loss.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Nanjing Vishee Medical Technology Co (SHSE:688580) has a 9-Day RSI of 39.54 as of Aug. 02, 2026. According to the industry distribution chart, Nanjing Vishee Medical Technology Co ranks #153 out of 865 companies in the Medical Devices & Instruments industry, placing it in the top 17.7%.
Is Nanjing Vishee Medical Technology Co's 9-Day RSI too high?
Nanjing Vishee Medical Technology Co's current 9-Day RSI is 39.54. The Medical Devices & Instruments industry median 9-Day RSI is 45.84. Nanjing Vishee Medical Technology Co's value of 39.54 is 13.7% below this industry median. Based on the distribution chart, Nanjing Vishee Medical Technology Co ranks #153 out of 865 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Nanjing Vishee Medical Technology Co has a GF Score™ of 91/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Nanjing Vishee Medical Technology Co's 9-Day RSI compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Nanjing Vishee Medical Technology Co ranks #153 out of 865 companies for 9-Day RSI. This places Nanjing Vishee Medical Technology Co in the top 18% of its industry — outperforming the majority of peers. The industry median 9-Day RSI is 45.84. Nanjing Vishee Medical Technology Co's value of 39.54 is 13.7% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 9-Day RSI for a Medical Devices & Instruments company?
The median 9-Day RSI among Medical Devices & Instruments companies is 45.84, based on 865 companies in the industry. Companies in the top quartile (top 25%) have a 9-Day RSI significantly above this median, while those in the bottom quartile fall well below. However, 9-Day RSI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Nanjing Vishee Medical Technology Co's current 9-Day RSI of 39.54 is 13.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 9-Day RSI mean?
A high 9-Day RSI can signal that a stock is expensive relative to its fundamentals. For the Medical Devices & Instruments industry, the median 9-Day RSI is 45.84 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Nanjing Vishee Medical Technology Co's current 9-Day RSI is 39.54. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nanjing Vishee Medical Technology Co stock overvalued right now?
Based on GuruFocus' analysis, Nanjing Vishee Medical Technology Co (SHSE:688580) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥54.59, compared to a current price of ¥47.10 — trading 13.7% below its estimated fair value. The current 9-Day RSI is 39.54 and 13.7% below the Medical Devices & Instruments industry median of 45.84. Nanjing Vishee Medical Technology Co's overall GF Score™ is 91/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 9-Day RSI calculated?
9-Day RSI is calculated from a company's financial statements. For Nanjing Vishee Medical Technology Co (SHSE:688580), the current 9-Day RSI is 39.54 as of Aug. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Nanjing Vishee Medical Technology Co (SHSE:688580) Overvalued in 2026?
Based on GuruFocus' analysis, Nanjing Vishee Medical Technology Co stock appears to be undervalued.
The current stock price of ¥47.10 is trading 13.7% below its estimated GF Value™ of ¥54.59.
GuruFocus considers Nanjing Vishee Medical Technology Co to be Modestly Undervalued.
Key valuation signals for SHSE:688580:
9-Day RSI: 39.54
GF Value™: ¥54.59 vs. price of ¥47.10 (13.7% below fair value)
Industry Position: 13.7% below the Medical Devices & Instruments median (#153 of 865)
No single metric tells the full story. See the SHSE:688580 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Nanjing Vishee Medical Technology Co Ltd is engaged in production and sales of rehabilitation medical devices. The company's products under Pelvic floor and postpartum rehabilitation include Pelvic floor electromyography biofeedback instrument; Myotrac series biological stimulation feedback instrument; Ruiyi Series Biostimulation Feedback Apparatus; Magneuro Series Magnetic Stimulator; Female psychological rehabilitation; Neonatal electroencephalograph; Consumables; and under Mental rehabilitation include Multi-parameter biofeedback instrument; Group biofeedback; Magneuro Series Magnetic Stimulator; and Cognitive dysfunction treatment software.
91GF Score
Get the complete analysis for SHSE:688580
9-Day RSI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688580 has been successfully added to your 
